Dr. Michael Manns on a Possible Link Between Hepatitis C and Hepatocellular Carcinoma

Publication
Video
HCC MonitorApril 2016
Volume 2
Issue 1

Michael Manns, MD, explains the possible link between hepatitis C and hepatocellular carcinoma.

Michael Manns, MD, director, Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hannover in Germany, explains the possible link between hepatitis C and hepatocellular carcinoma.

Manns says that patients who contracted hepatitis C or cirrhosis have showcased a greater risk of developing hepatocellular carcinoma (HCC), though drawing a direct link between the virus and HCC is difficult due to treatment of the virus depleting the potential control group. He concludes by pointing out that if a link is to be drawn between Hepatitis C and HCC, further testing must be done.

Articles in this issue
Dr. Michael Manns on a Possible Link Between Hepatitis C and Hepatocellular Carcinoma
Dr. Michael Manns on a Possible Link Between Hepatitis C and Hepatocellular Carcinoma
Dr. Anne Covey on Locoregional Therapy in Hepatocellular Carcinoma
Dr. Anne Covey on Locoregional Therapy in Hepatocellular Carcinoma
NCCN Guideline Calls Locoregional Therapy "Curative" for HCC
NCCN Guideline Calls Locoregional Therapy "Curative" for HCC
Genetically Modified T-Cell Therapy Cleared for Early Stage HCC Study
Genetically Modified T-Cell Therapy Cleared for Early Stage HCC Study
Neoadjuvant Sorafenib Induces Major Tumor Necrosis in HCC
Neoadjuvant Sorafenib Induces Major Tumor Necrosis in HCC
Committee Recommends Continuation of Phase III Tivantinib Study
Committee Recommends Continuation of Phase III Tivantinib Study
Liver Cancer Death Rates Defy Declining Trends
Liver Cancer Death Rates Defy Declining Trends
Moving Forward: Examining the Evolving Role of Embolization in HCC
Moving Forward: Examining the Evolving Role of Embolization in HCC
New Approaches to the Detection and Treatment of HCC With Portal Vein Thrombosis
New Approaches to the Detection and Treatment of HCC With Portal Vein Thrombosis
Novel Therapies on the Horizon in Hepatocellular Carcinoma
Novel Therapies on the Horizon in Hepatocellular Carcinoma

Newsletter

Stay up to date on practice-changing data in community practice.

Subscribe Now!
Recent Videos
2 experts in this video
The Evolving Role of Lenvatinib in the HCC Therapeutic Landscape
2 experts in this video
Second-Line Therapy in Advanced HCC: Treatment Considerations and Evolving Options
2 experts in this video
Lenvatinib in Advanced HCC: Considerations for Monotherapy and Combination Regimens
2 experts in this video
First-Line Therapy for Advanced HCC: The Role of TKIs and ICIs
1 expert in this video
Academic Perspectives on Systemic Therapy for Advanced uHCC
2 experts in this video
Considerations for Treatment Approaches in Intermediate-Stage HCC
2 experts in this video
Navigating the Evolving First-Line Treatment Regimens in Intermediate-Stage HCC
1 expert in this video
Optimizing Frontline TKI Therapy in Advanced uHCC: Managing Adverse Events
1 expert in this video
Clinical Pearls in Intermediate Stage uHCC Management
1 expert in this video
Lenvatinib and Depth of Response in Advanced uHCC: Insights From REFLECT
Related Content
Targeting FRα and B7-H4 in Endometrial Cancer

Targeting FRα and B7-H4 in Endometrial Cancer

Jax DiEugenio
April 9th 2025
Article

A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers evaluated.

Read More

Tailoring Treatments to Better Outcomes in Liver Cancer

Tailoring Treatments to Better Outcomes in Liver Cancer

Jordyn Sava;Susanne G. Warner, MD
October 13th 2023
Podcast

In season 4, episode 16 of Targeted Talks, Susanne G. Warner, MD,discusses the importance of tailoring treatments for patients with liver cancer, taking into account the staging of the cancer.

Listen

HIF-2α Inhibitors Make Significant Inroads in Renal Cell Carcinoma

HIF-2α Inhibitors Make Significant Inroads in Renal Cell Carcinoma

Tony Berberabe, MPH
April 7th 2025
Article

Read More

Insights from ASCO GI and the Future of CAR T-Cell Therapy in Solid Tumors

Insights from ASCO GI and the Future of CAR T-Cell Therapy in Solid Tumors

Robert L. Ferris, MD, PhD
April 4th 2025
Article

The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell therapies for solid tumors.

Read More

Survivorship Care Promotes Evidence-Based Approaches for Quality of Life and Beyond

Survivorship Care Promotes Evidence-Based Approaches for Quality of Life and Beyond

Jonah Feldman
March 21st 2025
Article

Frank J. Penedo, PhD, explains the challenges of survivorship care for patients with cancer and how he implements programs to support patients’ emotional, physical, and practical needs.

Read More

Lee Evaluates Chronic GVHD Therapies for Depth and Durability of Response

Lee Evaluates Chronic GVHD Therapies for Depth and Durability of Response

Targeted Oncology Staff
March 20th 2025
Article

During a live event, Catherine J. Lee, MD, MS, discussed the efficacy and safety results of various trials of approved agents for treating chronic graft-vs-host disease.

Read More